Back to search

Article

Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial

2020-06-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Anti-malarial resistance is a threat to recent gains in malaria control. This study aimed to assess the efficacy and safety of artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) in the management of uncomplicated malaria and to measure the prevalence of molecular markers of resistance of <italic>Plasmodium falciparum </italic>in sentinel sites in Mafe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ceda646-95ee-5d03-901d-e2e5d09b408c
DOI
10.21203/rs.2.21808/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trialDOI 10.21203/rs.2.21808/v3
Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016Semantic proximity
Assessing the Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Malaria in Lagos, Nigeria: A Comprehensive Study on Treatment Response and Resistance MarkersSemantic proximity
Proof of concept: Malaria rapid diagnostic tests and massively parallel sequencing for surveillance of molecular markers of antimalarial resistance in Bissau, Guinea-Bissau during 2014-2017Semantic proximity
Assessment of Molecular Markers of Anti-malarial Drug Resistance in Pfk13-propeller, Pfcrt and Pfmdr1 Genes in Plasmodium Falciparum Isolated From Patients Returning for Malaria Retreatment in Democratic Republic of Congo&nbsp;Semantic proximity
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western KenyaSemantic proximity
Molecular Markers of Antimalarial Resistance in Children with Uncomplicated Plasmodium falciparum at Two Sites in Liberia in 2022-2023Semantic proximity
Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.Semantic proximity
Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016–2017Semantic proximity
Therapeutic Efficacy of Artemether-Lumefantrine (AL) plus Single Low Dose Primaquine for the treatment of uncomplicated <i>falciparum</i> malaria in a high transmission setting, Western EthiopiaSemantic proximity
Clinical efficacy of artemisinin-lumefantrine and status of antifolate drug resistance markers in western KenyaSemantic proximity
Therapeutic efficacy of artemether–lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markersSemantic proximity
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.Semantic proximity
Select a neighboring publication to make it the new centre.